Pfm Health Sciences, LP Athira Pharma, Inc. Transaction History

Pfm Health Sciences, LP

  • $1.53 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$9.15 - $11.09 $6.21 Million - $7.52 Million
-678,247 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$10.24 - $20.87 $2.13 Million - $4.34 Million
208,020 Added 44.24%
678,247 $6.95 Million
Q4 2020

Feb 16, 2021
BUY
$16.48 - $34.3 $1.28 Million - $2.67 Million
77,738 Added 19.81%
470,227 $16.1 Million
Q3 2020

Nov 16, 2020
BUY
$16.02 - $18.46 $6.29 Million - $7.25 Million
392,489 New
392,489 $7.25 Million

Others Institutions Holding ATHA

# of Institutions
62
Shares Held
18.8M
Call Options Held
17.2K
Put Options Held
800
View Full List

About Athira Pharma, Inc.

ATHA Quotes by TradingView
  • Ticker ATHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,817,700
  • Market Cap $15.9M
  • Description
  • Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...
More about ATHA
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email